Access to anti-retroviral drugs, female in Fiji
Fiji: Access to anti-retroviral drugs, female was 18.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Fiji, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Fiji is 18.0%, measured in 2024.
The figure is up 50.0% on the previous year and down 62.5% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Fiji peaked at 98.0% in 2004 and was at its lowest, 0.0%, in 2000.
That places Fiji 141st out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Fiji, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 98.0% | — |
| 2005 | 87.0% | -11.2% |
| 2006 | 93.0% | +6.9% |
| 2007 | 74.0% | -20.4% |
| 2008 | 82.0% | +10.8% |
| 2009 | 74.0% | -9.8% |
| 2010 | 72.0% | -2.7% |
| 2011 | 60.0% | -16.7% |
| 2012 | 72.0% | +20.0% |
| 2013 | 54.0% | -25.0% |
| 2014 | 48.0% | -11.1% |
| 2015 | 36.0% | -25.0% |
| 2016 | 31.0% | -13.9% |
| 2017 | 30.0% | -3.2% |
| 2018 | 29.0% | -3.3% |
| 2019 | 27.0% | -6.9% |
| 2020 | 23.0% | -14.8% |
| 2021 | 23.0% | +0.0% |
| 2022 | 13.0% | -43.5% |
| 2023 | 12.0% | -7.7% |
| 2024 | 18.0% | +50.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 50.8% | 0.0% | 98.0% | 10 |
| 2010s | 45.9% | 27.0% | 72.0% | 10 |
| 2020s | 17.8% | 12.0% | 23.0% | 5 |
Countries ranked near Fiji
More gender data for Fiji
- Child population (UN estimates and projections) 241.74 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.8779 % change on previous year (2030)
- Population 711.37 (2030)
- Working-age population (UN estimates and projections) 711.37 (2030)
- Population (UN estimates and projections), annual growth rate 0.8456 % change on previous year (2030)
- Age population, age 00, female, interpolated 7,837 (2025)
- Age population, age 00, male, interpolated 8,368 (2025)
- Age population, age 01, female, interpolated 7,808 (2025)
- Age population, age 01, male, interpolated 8,329 (2025)
- Age population, age 02, female, interpolated 7,791 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Fiji?
- Access to anti-retroviral drugs, female in Fiji was 18.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Fiji?
- The highest recorded value was 98.0% in 2004.
- What is the lowest access to anti-retroviral drugs, female recorded in Fiji?
- The lowest recorded value was 0.0% in 2000.
- How does Fiji rank for access to anti-retroviral drugs, female?
- Fiji ranks 141st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Fiji?
- Over the last ten years it is down 62.5%. The long-run trend across the full record is volatile.
- Where does this Fiji data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.